BioSpace News Archive

United States Supreme Court Building in Washington DC, USA.

Drug shortages

Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability

Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.

November 26, 2024

·

4 min read

·

Ben Hargreaves

Pictured: AstraZeneca building in Gothenburg/iStoc

Prostate cancer

AstraZeneca’s Truqap Redeems Itself with Phase III Prostate Cancer Win

Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It helps AstraZeneca position itself as a top player in the prostate cancer space, alongside its Big Pharma colleagues.

November 26, 2024

·

2 min read

·

Tristan Manalac

Businessman climbing stairs on the top. Stock market price rising up in bull market. concept of ambition, confidence and success

Weight Loss

‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss

With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.

November 26, 2024

·

2 min read

·

Annalee Armstrong

Silhouette of a head with a cloud. Thought in the head of man. This is a 3d render illustration

Alzheimer’s disease

Alector’s AbbVie-Partnered Alzheimer’s Program Fails Phase II, Triggering a 17% Layoff

Alector is kicking off a resource realignment effort that will include a workforce reduction. The biotech expects its current cash position to last it through 2026.

November 26, 2024

·

2 min read

·

Tristan Manalac